Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2003
11/06/2003CA2480314A1 Method of separating poly-3-hydroxyalkanoic acid
11/06/2003CA2480291A1 Adipocyte complement related protein zacrp14
11/05/2003EP1359224A1 A process for production of polyunsaturated fatty acids by marine microorganisms
11/05/2003EP1359156A2 Papilloma virus vaccine
11/05/2003EP1358354A1 Method for identifying compounds modulating reverse cholesterol transport
11/05/2003EP1358353A2 Identification of genetic determinants of polymorphic cyp3a5 expression
11/05/2003EP1358347A2 Genes expressed in foam cell differentiation
11/05/2003EP1358337A1 Nucleotide sequences which code for the otsa gene of c. glutamicum
11/05/2003EP1358336A2 Human serine-threonine kinase
11/05/2003EP1358334A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
11/05/2003EP1358333A2 Genes encoding polypeptides from methylomonas sp. involved exopolysaccharide production
11/05/2003EP1358332A2 A serpin in bifidobacteria
11/05/2003EP1358330A2 Transporters and ion channels
11/05/2003EP1358329A2 Lipid-associated molecules
11/05/2003EP1358328A2 Regulation of human serotonin-like g protein-coupled recepter
11/05/2003EP1358327A2 Proteins and nucleic acids encoding same
11/05/2003EP1358326A2 Proteins associated with cell growth, differentiation, and death
11/05/2003EP1358325A2 Protein modification and maintenance molecules
11/05/2003EP1358323A2 Regulators of apoptosis
11/05/2003EP1358318A2 Hybridoma cell line g250 and its use for producing monoclonal antibodies
11/05/2003EP1358213A2 Humanized antibodies that recognize beta amyloid peptide
11/05/2003EP1358203A2 Methods and compositions for use in spliceosome mediated rna trans-splicing
11/05/2003EP1357940A2 Hepatitis b virus treatment
11/05/2003EP1357939A2 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof
11/05/2003EP1357938A2 Hyperblebbing bacterial strains and use thereof for production of vaccines
11/05/2003EP1357930A2 Histidine-rich glycoprotein
11/05/2003EP1357796A2 Control agents
11/05/2003EP0994945B1 Smad-interacting polypeptides and their use
11/05/2003EP0938506B1 Immunoglobulin superfamily domains and fragments with increased solubility
11/05/2003EP0934419B1 Method for preparing 2-hydroxy 4-methylthio butyric acid using a nitrilase
11/05/2003EP0863991B1 Antigenic preparations
11/05/2003EP0713495B1 Methods of enhancing bioactivity of chemokines
11/05/2003EP0489058B1 Cystic fibrosis gene
11/05/2003CN1454259A Talaromyces xylanases
11/05/2003CN1454257A Production of recombinant blood clotting factors in human cell lines
11/05/2003CN1454256A The high bone mass gene of 11q13.3
11/05/2003CN1454216A Antibodies to CCR5
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/05/2003CN1454191A A biological fertilizer based on yeasts
11/05/2003CN1454055A Method for producing working reagent and for biological prevention or control
11/05/2003CN1453514A Method and apparatus for improving indoor air quality with microbes
11/05/2003CN1126818C Process for producing nucleic acid inhibiting protein by inducing and cultivating trichoid root of Chinese trichosanthes
11/05/2003CN1126815C Novel microorganism streptomyces exfoliatus YJ-118 and method for producing pravastatin sodium by using strain
11/05/2003CN1126814C Preparation of galacto oligosaccharide and beta galactosidase enriched products permented using streptococcus thermophilus
11/05/2003CN1126568C Adjuvant used in vaccine
11/05/2003CN1126454C Control of enterohemorrhagic E Coli 0157:H7 of cattle with probiotic bacteria
11/04/2003US6642439 Basidiomycete manganese peroxidase gene-transferred plant and a method for removing an environmental contaminant using the same
11/04/2003US6642371 Haemophilus adherence and penetration proteins
11/04/2003US6642369 Nucleic acids involved in the responder phenotype and applications thereof
11/04/2003US6642368 Programmed cell death and caspase-12
11/04/2003US6642358 Receptor that binds trail
11/04/2003US6642207 Artificial chromosome constructs containing foreign nucleic acid sequences
11/04/2003US6642050 Three-dimensional cell culture material having sugar polymer containing cell recognition sugar chain
11/04/2003US6642044 α-amylase mutants
11/04/2003US6642040 Human cGMP-stimulated cyclic nucleotide phosphodiesterase
11/04/2003US6642038 GlcNAc phosphotransferase of the lysosomal targeting pathway
11/04/2003US6642031 Microorganisms with ability to degrade indole and enzymes therefrom
11/04/2003US6642029 Yeast cells comprising vectors are joined to leader and processing signals which provide for expression and secretion of the gene product; Saccharomyces
11/04/2003US6642027 Production of secreted polypeptides
11/04/2003US6642026 Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
11/04/2003US6642025 Chlamydia antigens and corresponding DNA fragments and uses thereof
11/04/2003US6642023 High molecular weight; encoded by isolated nucleic acid; expression vectors; use for diagnostics, prophylaxis and treatment of infections
11/04/2003US6642017 Modulating production of pneumococcal capsular polysaccharide
11/04/2003US6642011 Reducing allegenic response heterologous proteins; obtain nucleotide sequences of heterologous protein, insert subtilisin sequences, transform cell, expression vector, recover protein, monitor human to protein
11/04/2003US6641997 Tetrameric, two-transmembrane-domain-type bound to a solid support; substituting amino acids to permit binding to agitoxin; use in treating cardiac arrhythmia, diabetes, seizures, asthma and hypertension
11/04/2003US6641996 Isolated nucleic acid that hybridizes to the complement of given sequence; use in drug testing and cleaving prodrugs at target site
11/04/2003US6641812 Heat shock protein-based vaccines and immunotherapies
11/04/2003CA2106377C Ethanol production by recombinant hosts
11/04/2003CA2040555C Cloned glutamic acid decarboxylase
11/01/2003CA2391438A1 Psp94 diagnostic reagents and assays
10/2003
10/30/2003WO2003089901A2 Methods for preparing libraries of unique tags and related screening methods
10/30/2003WO2003089643A1 Novel proteins and dnas encoding the same
10/30/2003WO2003089627A1 Translocation dependent complementation for drug screening
10/30/2003WO2003089626A1 Transgenic saccharomyces cerevisiae and method for bioremediation
10/30/2003WO2003089625A2 Product
10/30/2003WO2003089624A2 Fc receptor homolog, reagents, and uses thereof
10/30/2003WO2003089621A2 Promoter and plasmid system for genetic engineering
10/30/2003WO2003089620A2 Phospholipases, nucleic acids encoding them and methods for making and using them
10/30/2003WO2003089614A2 Production of functional antibodies in filamentous fungi
10/30/2003WO2003089610A2 Fatty alcohol oxidase genes and proteins from candida troplicalis and methods relating thereto
10/30/2003WO2003089606A2 Thermostable dna polymerases and methods of making same
10/30/2003WO2003089605A2 Method of creating a library of bacterial clones with varying levels of gene expression
10/30/2003WO2003089600A2 Surface transfection and expression procedure
10/30/2003WO2003089589A2 Matrix analysis of gene expression in cells (magec)
10/30/2003WO2003089585A2 Methods of use of the enzymes of mycothiol synthesis
10/30/2003WO2003089571A2 Ehrlichia canis genes and vaccines
10/30/2003WO2003089466A1 Novel proteins and dnas encoding the same
10/30/2003WO2003089462A2 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
10/30/2003WO2003089455A2 Low-cost production of peptides
10/30/2003WO2003089454A2 Unnatural amino acid containing display libraries
10/30/2003WO2003089450A2 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003WO2003089015A2 Rapid sterilization and vaccine preparation
10/30/2003WO2003088998A1 Antibody combination useful for tumor therapy
10/30/2003WO2003088996A2 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines
10/30/2003WO2003088984A1 Compositions and methods for augmenting kidney function
10/30/2003WO2003088904A2 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003WO2003088808A2 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003WO2003056295A3 Enterococcal virulence factors
10/30/2003WO2003052059A3 Recombinant bovine thrombin
10/30/2003WO2003050233A3 Gene promoters
1 ... 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 ... 1489